183 related articles for article (PubMed ID: 35629120)
1. Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines.
Šubr V; Pola R; Gao S; Islam R; Hirata T; Miyake D; Koshino K; Zhou JR; Yokomizo K; Fang J; Etrych T
J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629120
[TBL] [Abstract][Full Text] [Related]
2. Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization.
Randárová E; Nakamura H; Islam R; Studenovský M; Mamoru H; Fang J; Chytil P; Etrych T
Acta Biomater; 2020 Apr; 106():256-266. PubMed ID: 32058082
[TBL] [Abstract][Full Text] [Related]
3. Polymer nanomedicines based on micelle-forming amphiphilic or water-soluble polymer-doxorubicin conjugates: Comparative study of in vitro and in vivo properties related to the polymer carrier structure, composition, and hydrodynamic properties.
Braunová A; Chytil P; Laga R; Šírová M; Machová D; Parnica J; Říhová B; Janoušková O; Etrych T
J Control Release; 2020 May; 321():718-733. PubMed ID: 32142741
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the pharmacological and biological properties of HPMA copolymer-pirarubicin conjugates: A single-chain copolymer conjugate and its biodegradable tandem-diblock copolymer conjugate.
Etrych T; Tsukigawa K; Nakamura H; Chytil P; Fang J; Ulbrich K; Otagiri M; Maeda H
Eur J Pharm Sci; 2017 Aug; 106():10-19. PubMed ID: 28528285
[TBL] [Abstract][Full Text] [Related]
5. Adaptable polymerization platform for therapeutics with tunable biodegradability.
Hrochová M; Kotrchová L; Frejková M; Konefał R; Gao S; Fang J; Kostka L; Etrych T
Acta Biomater; 2023 Nov; 171():417-427. PubMed ID: 37696413
[TBL] [Abstract][Full Text] [Related]
6. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours.
Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K
Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K
J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933
[TBL] [Abstract][Full Text] [Related]
8. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
[TBL] [Abstract][Full Text] [Related]
10. Structure-to-Efficacy Relationship of HPMA-Based Nanomedicines: The Tumor Spheroid Penetration Study.
Kudláčová J; Kotrchová L; Kostka L; Randárová E; Filipová M; Janoušková O; Fang J; Etrych T
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33419291
[TBL] [Abstract][Full Text] [Related]
11. Designing polymer conjugates as lysosomotropic nanomedicines.
Duncan R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
[TBL] [Abstract][Full Text] [Related]
13. Micelle-forming HPMA copolymer conjugates of ritonavir bound via a pH-sensitive spacer with improved cellular uptake designed for enhanced tumor accumulation.
Koziolová E; Machová D; Pola R; Janoušková O; Chytil P; Laga R; Filippov SK; Šubr V; Etrych T; Pechar M
J Mater Chem B; 2016 Dec; 4(47):7620-7629. PubMed ID: 32263818
[TBL] [Abstract][Full Text] [Related]
14. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia.
Tomalova B; Sirova M; Rossmann P; Pola R; Strohalm J; Chytil P; Cerny V; Tomala J; Kabesova M; Rihova B; Ulbrich K; Etrych T; Kovar M
J Control Release; 2016 Feb; 223():1-10. PubMed ID: 26708020
[TBL] [Abstract][Full Text] [Related]
15. HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery.
Chytil P; Kostka L; Etrych T
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33578756
[TBL] [Abstract][Full Text] [Related]
16. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
[TBL] [Abstract][Full Text] [Related]
17. Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis.
Libánská A; Randárová E; Skoroplyas S; Bartoš M; Luňáčková J; Lager F; Renault G; Scherman D; Etrych T
J Control Release; 2023 Jan; 353():30-41. PubMed ID: 36403682
[TBL] [Abstract][Full Text] [Related]
18. Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release.
Chytil P; Šírová M; Kudláčová J; Říhová B; Ulbrich K; Etrych T
Mol Pharm; 2018 Sep; 15(9):3654-3663. PubMed ID: 29543465
[TBL] [Abstract][Full Text] [Related]
19. Polymer nanomedicines with enzymatically triggered activation: A comparative study of in vitro and in vivo anti-cancer efficacy related to the spacer structure.
Pechar M; Pola R; Studenovský M; Bláhová M; Grosmanová E; Dydowiczová A; Filipová M; Islam R; Gao S; Fang J; Etrych T
Nanomedicine; 2022 Nov; 46():102597. PubMed ID: 36064033
[TBL] [Abstract][Full Text] [Related]
20. Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities.
Duncan R; Vicent MJ
Adv Drug Deliv Rev; 2010 Feb; 62(2):272-82. PubMed ID: 20005271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
